Tuesday, May 17, 2011

First Quarter results from Depuy, Stryker and Zimmer: Key players in the Hip replacement market

excerpts from an article by Laura Miller

DePuy Orthoapedics reported $811 million in sales during the first quarter of 2011, a 7.2 percent increase over the first quarter of last year. Johnson & Johnson, DePuy's parent company, reported $271 million in expenses from litigation and additional DePuy ASR Hip recall costs.

Stryker reported net sales of $2 billion during the first quarter, a 10.2 percent increase over the same period last year. Despite the increase, its knee sales decreased by 2 percent and its hip sales increased by 2 percent.

Zimmer reported $1.1 billion in nets sales for the first quarter, a 5 percent increase compared to the first quarter of 2010. The company's success was driven by its reconstructive products, contributing $842 million from worldwide sales.

No comments:

Post a Comment